We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cellectis Sub-Licenses its Homologous Recombination Technology to GlaxoSmithKline

News   May 08, 2007

 
Cellectis Sub-Licenses its Homologous Recombination Technology to GlaxoSmithKline
 
 
 

RELATED ARTICLES

What Can Salad Dressing Tell Us About Cancer? Think Oil & Vinegar

News

Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer.

READ MORE

Multiple Malware Threats for Visitors to Pirate Websites

News

Over 4 000 files containing malware or potentially unwanted programmes were retrieved from more than 1 000 websites suspected of sharing illegally protected content in an EU-wide research project carried out by the European Union Intellectual Property Office (EUIPO).

READ MORE

Marker Indicates Those at Higher Risk from Lethal Fungal Spores

News

Genetic mutation in humans linked to a 17-fold increase in the amount of dangerous fungal spores in the lungs.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE